Mindpeak

AI for pathology diagnosis

Hamburg, Germany

Mindpeak is a German health tech startup that develops AI-powered software for image recognition and analysis in digital pathology to improve cancer diagnostics.

Mindpeak hero image

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Mindpeak on @MedStartr Today Mindpeak is a German health tech startup that develops AI-powered software for image recognition and analysis in digital pathology to improve cancer diagnostics. #MentalBehavioralHealth #CancerOncology #PracticeManagement #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/G8DCqyjF6GQ

Get Involved in Mindpeak

How We Help

Problem Statement

The number of cancer experts is constant while the demand for medical image analysis is growing, leading to increased workloads. Mindpeak aims to improve the accuracy and speed of cancer diagnostics, reduce manual and repetitive tasks for pathologists, and enhance workflow efficiency.

Core Technology

Artificial Intelligence & Deep Learning

Key Differentiators

0-click solutions that work out-of-the-box without manual fine-tuning; Explainable AI (xAI) for transparency; Self-supervised learning methods

Clinical Focus

Pathology

Company Info

Business Model: Hybrid
Founded: 2018
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.mindpeak.ai/

Disease Areas

Mental Health Cancer & Oncology

Technologies

Deep LearningDigital PathologyImage RecognitionExplainable AISaaSAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

ASCO 2025 study with AstraZeneca demonstrated 40% improvement in HER2-ultralow case identification across 287 pathologists. Validated Ki-67 whole-slide scoring per IKWG protocol. Partnership with Discovery Life Sciences for clinical trial biomarker quantification. ISO 13485 certified.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Mindpeak?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.